The independent source for health policy research, polling, and news.
861 - 880 of 1,300 Results
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son ā and others who order medicine by mail ā could depend on it, she says.
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donāt have to.
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents ā inspection records, recalls, warning letters and lawsuits ā reveals how drugs that are poorly manufactured or contaminated can reach consumers.
The program that provides health care for about half of the U.S. territoryās population cannot afford to cover the drugs.
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listenersā questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHNās Julie Rovner.
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donāt have to.
The fallout continues from that Texas court decision that ruled Congressā 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. Meanwhile, enrollment for 2019 at healthcare.gov was down, but far less than many predicted. KHNās Julie Rovner, along with panelists Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of the Washington Examiner, discuss this, plus the best, most overhyped and nerdiest stories of 2018. Also, Rovner interviews GOP strategist and pollster Frank Luntz.
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from ābiosimilars.ā Itās a very different story in Europe.
The leaders of Californiaās legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donāt have to.
The U.S. surgeon general has called on "bystanders" to be equipped with the opioid reversal drug to save lives. But when a nurse answered that call, her application for life insurance was denied. Why?
Itās a little-known secret that patients can get thousands of dollars directly from a drugmaker.
The price of insulin keeps going up. For people with Type 1 diabetes, high prices can be a life-or-death issue. Now a grass-roots movement is pushing for change.
The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say āwallet biopsiesā are common.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donāt have to.
Ā© 2026 KFF